-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

732A.O2.6 732. Clinical Allogeneic Transplantation: Results I

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Biological, AML, Adult, ALL, Leukemia, Diseases, bone marrow, Non-Biological, Therapies, Elderly, MDS, Biological Processes, Technology and Procedures, Immune Disorders, Study Population, Lymphoid Malignancies, Myeloid Malignancies, Clinically relevant, genomics, hematopoiesis, transplantation, stem cells, NGS
Saturday, December 5, 2020: 7:30 AM-9:00 AM
Moderators:
Lynette C.Y. Chee, MBBS, PhD, FRACP, FRCPA, The Royal Melbourne Hospital and Kristin M. Page, MD, Duke University Medical Center
Disclosures:
Chee: Novartis: Other: Travel support for attendance at investigator meeting.
7:30 AM

Ryotaro Nakamura, M.D.1, Wael Saber, MD, MS2, Michael J Martens, PhD3*, Alyssa Ramirez3*, Bart L. Scott, MD4, Betul Oran, MD, MS5, Eric Leifer, Ph.D.6*, Roni Tamari, MD7, Asmita Mishra, MD8*, Richard T. Maziarz, MD9, Joseph P. McGuirk, DO10, Peter Westervelt, MD, PhD11, Sumithra Vasu, MD, MBBS12, Mrinal M. Patnaik, MD, MBBS13, Rammurti Kamble, MD14, Stephen J. Forman, MD1, Mikkael A. Sekeres15, Frederick R. Appelbaum, MD4, Adam M. Mendizabal, MS3*, Brent Logan, PhD16*, Mary M. Horowitz, MD, MS16 and Corey Cutler, MD, MPH, FRCPC 17

1Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
2CIBMTR, Medical College of Wisconsin, Milwaukee, WI
3The Emmes Company, Rockville, MD
4Fred Hutchinson Cancer Research Center, Seattle, WA
5Stem Cell Transplantation and Cellular Therapy, The University of Texas, MD Anderson Cancer Center, Houston, TX
6Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
7Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
8Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
9Knight Cancer Institute, Oregon Health and Science University, Portland, OR
10Department of Blood and Bone Marrow Transplant, The University of Kansas Medical Center, Kansas City, KS
11Washington University School of Medicine, Saint Louis, MO
12Ohio State University Wexner Medical Center, Columbus, OH
13Division of Hematology, Mayo Clinic, Rochester, MN
14Baylor College of Medicine Methodist Hospital, Houston, TX
15Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
16Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
17Division of Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Inst., Boston, MA

7:45 AM

Mahasweta Gooptu, MD1, Andrew St. Martin, MS2*, Rizwan Romee, MD3, Mukta Arora, MD4, Monzr M. Al Malki, MD5, Joseph H. Antin, MD3, Christopher Bredeson, MD, FRCPC, MSc6, Claudio G. Brunstein, MD, PhD4, Saurabh Chhabra, MD, MS7, Ephraim J. Fuchs, MD, MBA8, Nilanjan Ghosh, MD, PhD9, Michael R. Grunwald, MD9, Yoshihiro Inamoto, MD10, Christopher G. Kanakry, MD11*, Natasha Kekre, MD, MPH, FRCPC6, Joseph P. McGuirk, DO12, Ian K. McNiece, PhD13*, Rohtesh S. Mehta, MD, MPH, MS14, Marco Last Mielcarek, MD15*, Filipo Milano, MD, PhD16, Dipenkumar Modi, MD17, Ran Reshef, MD18, Mark A. Schroeder, MD19, Robert J. Soiffer, MD3, Scott R. Solomon, MD20, Edmund K. Waller, PhD, MD21 and Mary Eapen, MBBS, MS22

1Harvard Medical School, Boston, MA
2CIBMTR Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
3Dana-Farber Cancer Institute, Department of Hematologic Malignancies and Harvard Medical School, Boston, MA
4Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
5City of Hope, Duarte, CA
6Hematology, The Ottawa Hospital General Campus, Ottawa, ON, Canada
7Medical College of Wisconsin, Milwaukee, WI
8Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
9Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
10Clinical Research Division, Fred Hutchinson Cancer Research Center, Tokyo, Japan
11The Johns Hopkins Sidney Kimmel Comrehensive Cancer Ctr., Baltimore, MD
12The University of Kansas Cancer Center, Westwood, KS
13CellMED Consulting, Miami, FL
14Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
15Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
16Fred Hutchinson Cancer Research Center, Seattle, WA
17Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute/Wayne State University, Detroit, MI
18Columbia University Irving Medical Center, New York, NY
19Division of Oncology, Washington University, St. Louis, MO
20Blood and Marrow Transplant Program, BMT Group of Georgia, Atlanta, GA
21Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA
22CIBMTR department of Medicine, Medical College of Wisconsin, Milwaukee, WI

8:00 AM

Robert Zeiser, MD1, Nicola Polverelli, MD, PhD2*, Ron Ram, MD3*, Shahrukh K. Hashmi, MD, MPH4, Ronjon Chakraverty, BMBS, PhD5*, Mary E. D. Flowers, MD6, Fitzroy Dawkins, MD7*, Norbert Hollaender, MD8*, Maanasa Gowda, PharmD9*, Tommaso Stefanelli, MD8*, Stephanie J. Lee, MD, MPH6, Takanori Teshima, MD10 and Franco Locatelli, MD, PhD11

1Medical Center - University of Freiburg, Freiburg Im Breisgau, Germany
2Unit of Blood Diseases and Stem Cell Transplantation; Department of Clinical and Experimental Sciences, ASST Spedali Civili di Brescia, University of Brescia, Brescia, ITA
3BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
4Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
5UCL Cancer Institute; Institute of Immunity and Transplantation, London, United Kingdom
6Fred Hutchinson Cancer Research Center, Seattle, WA
7Incyte Corporation, Wilmington, DE
8Novartis Pharma AG, Basel, Switzerland
9Novartis Pharmaceuticals Corporation, East Hanover, NJ
10Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan
11Dipartimento di Oncoematologia Pediatrica, IRCCS, Ospedale Pediatrico Bambino Gesu', Sapienza, Università di Roma, Rome, Italy

8:15 AM

Daniel A. Pollyea, MD1, Amanda Winters, MD, PhD2, Craig T. Jordan, PhD3, Clayton Smith, MD4 and Jonathan A. Gutman, MD5

1Division of Hematology, University of Colorado Denver, Aurora, CO
2Department of Pediatrics, University of Colorado, Aurora, CO
3Division of Hematology, Department of Medicine, Univ. of Colorado, Denver, Aurora, CO
4University of Colorado Denver, Aurora, CO
5Division of Hematology, University of Colorado, Aurora, CO

8:30 AM

Joshua A Fein, MD1,2, Roni Shouval, MD, PhD3, Myriam Labopin, MD4,5*, Fabio Ciceri, MD6*, Emanuele Angelucci, MD7, Didier Blaise, MD8, Johanna Tischer9*, William Arcese, MD, PhD10, Yener Koc, MD11, Benedetto Bruno, MD12*, Jose L. Diez-Martin, MD, PhD13, Stella Santarone, MD14, Simona Sica, MD, PhD15*, Jurjen Versluis16*, Mohamad Mohty, MD, PhD17,18 and Arnon Nagler, MD19,20

1Department of Internal Medicine, UConn Health, West Hartford, CT
2Department of Internal Medicine, UConn Health, Farmington, CT
3Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Sorbonne Universités, UPMC Univ Paris 06, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France
5EBMT ALWP, Paris, France
6San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy
7Hematology and Transplant Center, IRCCS Ospedale Policlinico San Martino, Genova, Italy
8Institut Paoli Calmettes, Marseille, France
9Department of Internal Medicine III, University Hospital of Munich-Grosshadern, Ludwig-Maximilians University, Munich, Germany, Munich, Germany
10Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
11Medicana International, Istanbul, TUR
12SSCVD Trapianto di Cellule Staminali, AOU Città della Salute e della Scienza di Torino, Torino, Italy
13Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
14Department of Oncology Hematology, Pescara Hospital, Pescara, Italy
15Fondazione Policlinico A. Gemelli IRCCS, Roma, Italy; Istituto di Ematologia, Università Cattolica del Sacro Cuore, Roma, Italy, Roma, Italy
16Erasmus University Medical Center Cancer Institute, Rotterdam, Rotterdam, Netherlands
17Hospital Saint-Antoine, Paris University UPMC, INSERM U938, Paris, France
18EBMT, Acute Leukemia Working Party, Paris, France
19EBMT, Acute Leukemia Working Party office, Paris, France
20Division of Hematology, Sheba Medical Center, Tel Hashomer, Israel

8:45 AM

Christopher J. Gibson, MD1, Haesook T. Kim, PhD2, H. Moses Murdock, MD3, Bryan Hambley, MD4, Lin Zhao, MD5*, Lisa Green, PhD6*, Mark Fleharty6*, Brendan Blumenstiel6*, Carrie Cibulskis, BSc6*, Christopher D Gocke, MD7*, Sarah Nikiforow, MD, PhD1*, Amy E. DeZern, MD4, Vincent T. Ho, MD1*, Richard J. Jones, MD4, Niall Lennon, PhD6*, Jerome Ritz, MD1, Robert J. Soiffer, MD1, Lukasz P. Gondek, MD, PhD8 and R. Coleman Lindsley, MD, PhD1

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
3Department of Medicine, Brigham and Women's Hospital, Boston, MA
4Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
5Department of Hematology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
6Genomics Platform, Broad Institute, Cambridge, MA
7Division of Molecular Pathology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
8Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

*signifies non-member of ASH